Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeHealth

      Health

      CENTENE CORPORATION APPOINTS ASHLEE KNUCKEY AS CHIEF ETHICS AND COMPLIANCE OFFICER
      Health

      CENTENE CORPORATION APPOINTS ASHLEE KNUCKEY AS CHIEF ETHICS AND COMPLIANCE OFFICER

      September 1, 2022
      CooperCompanies Announces Third Quarter 2022 Results
      Health

      CooperCompanies Announces Third Quarter 2022 Results

      September 1, 2022
      Veeva Announces Fiscal 2023 Second Quarter Results
      Health

      Veeva Announces Fiscal 2023 Second Quarter Results

      September 1, 2022
      Zimmer Biomet and Surgical Planning Associates Announce Exclusive Multi-Year Co-Marketing Agreement for HipInsight(TM) Mixed Reality System for Total Hip Replacement
      Health

      Zimmer Biomet and Surgical Planning Associates Announce Exclusive Multi-Year Co-Marketing Agreement for HipInsight(TM) Mixed Reality System for Total Hip Replacement

      September 1, 2022
      Amarin to Present at H.C. Wainwright’s 24th Annual Global Investment Conference
      Health

      Amarin to Present at H.C. Wainwright’s 24th Annual Global Investment Conference

      August 31, 2022
      BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Cell Therapy Heart Failure Trial
      Health

      BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Cell Therapy Heart Failure Trial

      August 31, 2022
      Dr. David Brailer, M.D., Ph.D. Joins Cigna as Executive Vice President and Chief Health Officer
      Health

      Dr. David Brailer, M.D., Ph.D. Joins Cigna as Executive Vice President and Chief Health Officer

      August 31, 2022
      Illumina Deepens Commitment to Customers in China with New Manufacturing Site
      Health

      Illumina Deepens Commitment to Customers in China with New Manufacturing Site

      August 31, 2022
      Outlook Therapeutics® Re-Submits Biologics License Application for ONS-5010 as a Treatment for Wet AMD to the U.S. Food and Drug Administration
      Health

      Outlook Therapeutics® Re-Submits Biologics License Application for ONS-5010 as a Treatment for Wet AMD to the U.S. Food and Drug Administration

      August 31, 2022
      Y-mAbs and Takeda Announces Marketing Authorization in Israel for DANYELZA® (naxitamab-gqgk) for Neuroblastoma
      Health

      Y-mAbs and Takeda Announces Marketing Authorization in Israel for DANYELZA® (naxitamab-gqgk) for Neuroblastoma

      August 31, 2022
      « 1 … 227 228 229 230 231 … 246 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026